LifeEDIT Therapeutics Overview

  • Year Founded
  • 2017

Year Founded

  • Status
  • Acquired/​Merged

  • Employees
  • 88

Employees

  • Latest Deal Type
  • M&A

  • Financing Rounds
  • 1

LifeEDIT Therapeutics General Information

Description

Developer of a genome editing platform designed for dna modifications. The company offers rna-guided nucleases, base editors, reverse transcriptase editors, epigenetic editors, delivery systems and manufacturing processes, enabling biopharmaceutical firms to identify therapeutic candidates for genetic disorders.

Contact Information

Ownership Status
Acquired/Merged
Financing Status
Corporate Backed or Acquired
Corporate Office
  • 300 Morris Street
  • Suite 300
  • Durham, NC 27701
  • United States
Primary Industry
Drug Discovery
Other Industries
Biotechnology
Discovery Tools (Healthcare)
Acquirer
Corporate Office
  • 300 Morris Street
  • Suite 300
  • Durham, NC 27701
  • United States

Want detailed data on 11M+ companies?

What you see here scratches the surface

Request a free trial

Want to dig into this profile?

We’ll help you find what you need

Learn more

LifeEDIT Therapeutics Valuation & Funding

Deal Type Date Amount Valuation/
EBITDA
Post-Val Status Debt

This information is available in the PitchBook Platform. To explore LifeEDIT Therapeutics‘s full profile, request access.

Request a free trial

LifeEDIT Therapeutics Patents

LifeEDIT Therapeutics Recent Patent Activity

Publication ID Patent Title Status First Filing Date Technology (CPC) Citations
WO-2026003754-A1 Novel reverse transcriptases and uses thereof Pending 25-Jun-2024
AU-2025222029-A1 Novel rna-guided nucleases and proteins for polymerase editing Pending 12-Feb-2024
WO-2025174908-A1 Novel rna-guided nucleases and proteins for polymerase editing Pending 12-Feb-2024
WO-2025083619-A1 Rna-guided nucleases and acive fragments and variants thereof and methods of use Inactive 18-Oct-2023
AU-2024361267-A1 Rna-guided nucleases and active fragments and variants thereof and methods of use Pending 18-Oct-2023 C12N9/22
To view LifeEDIT Therapeutics’s complete patent history, request access »

LifeEDIT Therapeutics Signals

Growth Rate

Weekly
Growth
Weekly Growth

Size Multiple

Median
Size Multiple

Key Data Points

Similarweb Unique Visitors

Majestic Referring Domains

PitchBook’s non-financial metrics help you gauge a company’s traction and growth using web presence and social reach.

Request a free trial

LifeEDIT Therapeutics Former Investors

Investor Name Investor Type Holding Investor Since Participating Rounds Contact Info

This information is available in the PitchBook Platform. To explore LifeEDIT Therapeutics‘s full profile, request access.

Request a free trial

LifeEDIT Therapeutics FAQs

  • When was LifeEDIT Therapeutics founded?

    LifeEDIT Therapeutics was founded in 2017.

  • Where is LifeEDIT Therapeutics headquartered?

    LifeEDIT Therapeutics is headquartered in Durham, NC.

  • What is the size of LifeEDIT Therapeutics?

    LifeEDIT Therapeutics has 88 total employees.

  • What industry is LifeEDIT Therapeutics in?

    LifeEDIT Therapeutics’s primary industry is Drug Discovery.

  • Is LifeEDIT Therapeutics a private or public company?

    LifeEDIT Therapeutics is a Private company.

  • What is LifeEDIT Therapeutics’s current revenue?

    The current revenue for LifeEDIT Therapeutics is .

  • Who are LifeEDIT Therapeutics’s investors?

    AgBiome has invested in LifeEDIT Therapeutics.

  • When was LifeEDIT Therapeutics acquired?

    LifeEDIT Therapeutics was acquired on 16-Nov-2020.

  • Who acquired LifeEDIT Therapeutics?

    LifeEDIT Therapeutics was acquired by ElevateBio.

Data Transparency

  • Meet our data hygiene team

    Discover how our experts ensure you’re getting the most accurate financial data in the industry.

    Read more
  • How PitchBook sources data

    Our data operations team has logged over 3.5 million hours researching, organizing, and integrating the information you need most.

    Discover our process